We are live on ! Find out more
Canada Life

Canada Life Portfolio holdings

AUM $55.8B
1-Year Est. Return 26.04%
This Fund
S&P 500
This Quarter Est. Return
-1.4%
1 Year Est. Return
+26.04%
3 Year Est. Return
+87.85%
5 Year Est. Return
+117.08%
10 Year Est. Return
+382.61%
AUM
$55.8B
AUM Growth
-$1.65B
Cap. Flow
+$525M
Cap. Flow %
0.94%
Top 10 Hldgs %
30.27%
Holding
1,875
New
5
Increased
811
Reduced
731
Closed
34

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$293M
2
MSFT icon
Microsoft
MSFT
+$93.4M
3
MA icon
Mastercard
MA
+$72.9M
4
NVDA icon
NVIDIA
NVDA
+$48.5M
5
POOL icon
Pool Corp
POOL
+$44.4M

Sector Composition

Rank Sector Weight
1 Technology 30%
2 Financials 12.54%
3 Healthcare 10.67%
4 Consumer Discretionary 10.14%
5 Communication Services 9.74%

No holdings matched the selected filter criteria.

Similar funds

Canada Life's Q1 2026 Portfolio in Review

As of Q1 2026, Canada Life held 1,875 positions worth $55.8B, down 2.9% from $57.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 2.1%. Canada Life opened 5 new positions and exited 34, leaving the 1,875-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.

  • Canada Life's largest Q1 2026 buy was Kodiak Sciences: 4,951 shares worth $189K.
  • Canada Life added most to AstraZeneca in Q1 2026, an estimated $293M increase.
  • Canada Life's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $103M.
  • Canada Life fully exited iShares MSCI ACWI ETF in Q1 2026, selling an estimated $66.2M.
  • Canada Life's ten largest holdings make up 30% of its $55.8B portfolio in Q1 2026.
  • Canada Life opened 5 new positions and closed 34 in Q1 2026.
  • Canada Life's portfolio value fell 2.9% quarter-over-quarter to $55.8B.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.